Home
Home

M&A

Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge

Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge
Yahoo/AP

BioScrip buying CarePoint for $223 million to expand at-home drug infusion business

BioScrip buying CarePoint for $223 million to expand at-home drug infusion business
Yahoo/AP

Teva buys MicroDose for $165 million

Teva buys MicroDose for $165 million
First Word

Medivation retreats after J&J beefs up prostate cancer slate

Medivation retreats after J&J beefs up prostate cancer slate
The Fly on the Wall

Orphan drugmaker ViroPharma attracts takeover interest: sources

Orphan drugmaker ViroPharma attracts takeover interest: sources
Reuters

Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now

Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
TheStreet.com

J&J to Buy Aragon Pharmaceuticals for Cancer Candidate

J&J to Buy Aragon Pharmaceuticals for Cancer Candidate
Bloomberg

Elan Is In Play

Elan Is In Play
Seeking Alpha

Elan Inviting Royalty Pharma Bid Shows Hostility Easing

Elan Inviting Royalty Pharma Bid Shows Hostility Easing
Bloomberg

Mindray commits $105M to grab U.S. ultrasound imaging company

Mindray commits $105M to grab U.S. ultrasound imaging company
FierceMedicalDevice